Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Corvia Medical has raised $55.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Corvia Medical's investors include General Catalyst, Third Rock Ventures, Accelmed, Lumira Ventures.
Corvia Medical is headquartered in Andover, United States.
Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Corvia Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Corvia Medical — Funding & Investors." VCBacked, June 17, 2025, https://www.vcbacked.co/company/corvia-medical. Accessed July 20, 2026.
VCBacked. (2025). Corvia Medical — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/corvia-medical
{{cite web |title=Corvia Medical — Funding & Investors |url=https://www.vcbacked.co/company/corvia-medical |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated